BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29328556)

  • 1. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.
    Patel SS; Nabi E; Guzman L; Abbate A; Bhati C; Stravitz RT; Reichman T; Matherly SC; Driscoll C; Lee H; Luketic VA; Sterling RK; Sanyal AJ; Patel V; Levy M; Siddiqui MS
    Liver Transpl; 2018 Mar; 24(3):333-342. PubMed ID: 29328556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation.
    Patel SS; Guzman LA; Lin FP; Pence T; Reichman T; John B; Celi FS; Liptrap E; Bhati C; Siddiqui MS
    Liver Transpl; 2018 Jul; 24(7):872-880. PubMed ID: 29624871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery disease and its risk factors in patients presenting for liver transplantation.
    Gologorsky E; Pretto EA; Fukazawa K
    J Clin Anesth; 2013 Dec; 25(8):618-23. PubMed ID: 23994032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
    An J; Shim JH; Kim SO; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Circulation; 2014 Oct; 130(16):1353-62. PubMed ID: 25095888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients.
    Romero-Cristóbal M; Mombiela T; Caballero A; Clemente A; Fernández-Yunquera A; Diaz-Fontenla F; Rincón D; Ripoll C; Bermejo J; Catalina MV; Matilla AM; Ibáñez-Samaniego L; Pérez-Peña J; López-Baena JÁ; Díaz-Zorita B; Fernández-Avilés F; Salcedo MM; Bañares R
    Liver Transpl; 2019 Aug; 25(8):1177-1186. PubMed ID: 31106506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of Dobutamine Stress Echocardiography in End-Stage Liver Disease.
    Doytchinova AT; Feigenbaum TD; Pondicherry-Harish RC; Sepanski P; Green-Hess D; Feigenbaum H; Sawada SG
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2115-2122. PubMed ID: 30660519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
    Steinkohl F; Barbieri F; Senoner T; Strobl S; Finkenstedt A; Plank F; Langer C; Beyer C; Birkl K; Widmann G; Zoller H; Dichtl W; Friedrich G; Tilg H; Feuchtner G
    Eur Radiol; 2021 Jan; 31(1):494-503. PubMed ID: 32749590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Liver Transplantation in Patients With Preexisting Coronary Artery Disease.
    Reznicek E; Sasaki K; Montane B; Sims A; Beard J; Fares M; Sharma V; Cywinski J; Quintini C; Aucejo FN; Eghtesad B; Miller CM; Menon KVN
    Transplantation; 2023 Apr; 107(4):933-940. PubMed ID: 36397734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease.
    Patel S; Kiefer TL; Ahmed A; Ali ZA; Tremmel JA; Lee DP; Yeung AC; Fearon WF
    Am J Cardiol; 2011 Dec; 108(11):1552-5. PubMed ID: 21890080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of coronary artery disease in potential liver transplant recipients.
    Hogan BJ; Gonsalkorala E; Heneghan MA
    Liver Transpl; 2017 Mar; 23(3):386-395. PubMed ID: 27875636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Satapathy SK; Vanatta JM; Helmick RA; Flowers A; Kedia SK; Jiang Y; Ali B; Eason J; Nair SP; Ibebuogu UN
    Transplantation; 2017 Apr; 101(4):793-803. PubMed ID: 28099403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach.
    Trevisan L; Cautela J; Resseguier N; Laine M; Arques S; Pinto J; Orabona M; Barraud J; Peyrol M; Paganelli F; Bonello L; Thuny F
    Arch Cardiovasc Dis; 2018 Feb; 111(2):109-118. PubMed ID: 29031580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic characteristics of coronary artery disease in patients undergoing diagnostic coronary angiography at a tertiary hospital in Tanzania.
    Meda JR; Kusima HL; Magitta NF
    BMC Cardiovasc Disord; 2024 Feb; 24(1):125. PubMed ID: 38408906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry.
    Schulman-Marcus J; Hartaigh BÓ; Gransar H; Lin F; Valenti V; Cho I; Berman D; Callister T; DeLago A; Hadamitzky M; Hausleiter J; Al-Mallah M; Budoff M; Kaufmann P; Achenbach S; Raff G; Chinnaiyan K; Cademartiri F; Maffei E; Villines T; Kim YJ; Leipsic J; Feuchtner G; Rubinshtein R; Pontone G; Andreini D; Marques H; Shaw L; Min JK
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):364-372. PubMed ID: 27056154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.